T-Cure Bioscience Revenue and Competitors
Estimated Revenue & Valuation
- T-Cure Bioscience's estimated annual revenue is currently $1.1M per year.
- T-Cure Bioscience's estimated revenue per employee is $155,000
Employee Data
- T-Cure Bioscience has 7 Employees.
- T-Cure Bioscience grew their employee count by -30% last year.
T-Cure Bioscience's People
Name | Title | Email/Phone |
---|---|---|
1 | Senior Scientist | Reveal Email/Phone |
2 | Laboratory Research Assistant | Reveal Email/Phone |
3 | Senior Associate Scientist | Reveal Email/Phone |
T-Cure Bioscience Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is T-Cure Bioscience?
Founded by early pioneers of T cell receptor (TCR) therapy, T-Cure strives to find cure of human cancer using its cutting edge TCR-T technologies. Using its proprietary iSORT TCR discovery platform, T-Cure expects to rapidly grow its pipeline of therapy candidates. The Company believes its TCR hold great promise in treating patients unaddressed by current modalities.
keywords:N/AN/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
-30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.7M | 7 | 17% | N/A |
#2 | $0.5M | 7 | 0% | N/A |
#3 | $0.7M | 9 | 0% | N/A |
#4 | $0.7M | 9 | 29% | N/A |
#5 | $0.7M | 9 | -10% | N/A |